产品名称	AN3CA人子宫内膜癌细胞
货号	ZQ0471
产品介绍	An3 Ca细胞系来源于人类子宫内膜腺癌，这是一种起源于子宫内膜的癌症。该细胞系雌激素受体阴性(ER-)，在体内评估时显示出侵袭性致瘤潜力。An3 Ca细胞被广泛用于研究子宫内膜癌进展的分子和细胞机制，包括癌细胞增殖、转移和对治疗药物反应的研究。该细胞具有典型的上皮形态，并已被用于研究各种遗传和环境因素对癌细胞行为的影响。使用该细胞系的研究有助于确定潜在的治疗靶点和了解对常规治疗的耐药机制。它为评估新的药物或治疗策略提供了一个有价值的模型，可以有效地对抗侵袭性子宫内膜癌。总的来说，an3ca细胞系有助于推进子宫内膜腺癌的科学知识，为这种具有挑战性且通常致命的疾病提供更有效的干预措施。 注意事项： AN3 CA细胞生长密度高时有圆形细胞和不规则上皮样细胞两种形态，胞体上有黑色颗粒属于正常现象。
种属	人
性别/年龄	女/55岁
组织	子宫；子宫内膜
疾病	腺癌
细胞类型	肿瘤细胞
形态学	上皮的
生长方式	贴壁
倍增时间	大约45~55小时
培养基和添加剂	MEM（含NEAA）基础培养基（品牌：中乔新舟  货号：ZQ-300）+10%胎牛血清（中乔新舟 货号：ZQ0500）+1% Sodium Pyruvate 100 mM Solution（中乔新舟  货号：CSP003）+1%双抗（中乔新舟  货号：CSP006）
推荐完全培养基货号	ZM0471
生物安全等级	BSL-1
STR位点信息	Amelogenin: X CSF1PO: 13* D13S317: 12,14 D16S539: 10,14 D5S818: 11,14 D7S820: 7*,10,7.1 THO1: 10,9.3* TPOX: 8,10 vWA: 14,20 *Note: This
培养条件	95%空气，5%二氧化碳；37℃
抗原表达/受体表达	***
基因表达	***
保藏机构	ATCC; HTB-111 DSMZ; ACC-267
供应限制	仅供科研使用

货号	ZQ0471
发货规格	活细胞：T25培养瓶*1瓶或者1ml 冻存管*1支（细胞量约为5 x 10^5 cells/vial）二选一
发货形式	活细胞：常温运输；冻存管：干冰运输
储存温度	活细胞：培养箱；冻存管：液氮罐
产地	中国
供应限制	仅供科研使用

论文标题：  Dachsous cadherin related 1 (DCHS1) is a novel biomarker for immune infiltration and epithelial-mesenchymal transition in endometrial cancer via pan-cancer analysis
DOI：10.1186/s13048-024-01478-1.
发表时间： 2024-8-9
期刊： Journal of Ovarian Research
影响因子： 3.8
货号： ZQ0471
产品名称：AN3CA

原文链接：https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-024-01478-1

PubMed=14207855; DOI=10.1093/jnci/33.3.441
Dawe C.J., Banfield W.G. II, Morgan W.D., Slatick M.S., Ollendorf-Curth H.
Growth in continuous culture, and in hamsters, of cells from a neoplasm associated with acanthosis nigricans.
J. Natl. Cancer Inst. 33:441-456(1964)

PubMed=327080; DOI=10.1093/jnci/59.1.221
Fogh J., Fogh J.M., Orfeo T.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
J. Natl. Cancer Inst. 59:221-226(1977)

PubMed=6220172
Dracopoli N.C., Fogh J.
Polymorphic enzyme analysis of cultured human tumor cell lines.
J. Natl. Cancer Inst. 70:469-476(1983)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=11668190; DOI=10.1177/002215540104901105
Quentmeier H., Osborn M., Reinhardt J., Zaborski M., Drexler H.G.
Immunocytochemical analysis of cell lines derived from solid tumors.
J. Histochem. Cytochem. 49:1369-1378(2001)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=20218740; DOI=10.1177/153303461000900207
Wang Y.-M., Yang D., Cogdell D., Hu L.-M., Xue F.-X., Broaddus R., Zhang W.
Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma.
Technol. Cancer Res. Treat. 9:179-189(2010)

PubMed=20944090; DOI=10.1126/scitranslmed.3001538
Dedes K.J., Wetterskog D., Mendes-Pereira A.M., Natrajan R., Lambros M.B., Geyer F.C., Vatcheva R., Savage K., Mackay A., Lord C.J., Ashworth A., Reis-Filho J.S.
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors.
Sci. Transl. Med. 2:53ra75.1-53ra75.8(2010)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017
Korch C.T., Spillman M.A., Jackson T.A., Jacobsen B.M., Murphy S.K., Lessey B.A., Jordan V.C., Bradford A.P.
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.
Gynecol. Oncol. 127:241-248(2012)